Loading
NASDAQIndustrialsSpecialty Business Services
Latest quote
$86.40
−$2.39 · -2.69%
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
Latest quote
$86.40
−$2.39 · -2.69%
After-hours
$86.2697
−$0.1303 · -0.15%
Oct 8, 6:04 PM ET
Regular session · ET · Market data may be delayed.
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
Day range
Current $86.40
52-week range
Current $86.40
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
16
Overpriced
Sentiment
57
Mixed
Risk
34
Moderate Risk
Momentum
66
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
Day range
Current $86.40
52-week range
Current $86.40
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 331.88M USD | 278.42M USD | 259.48M USD | 230.57M USD | 204.96M USD |
| Cost of goods sold | 223.57M USD | 188.97M USD | 175.68M USD | 162.21M USD | 146.52M USD |
| Gross profit | 108.3M USD | 89.45M USD | 83.81M USD | 68.36M USD | 58.44M USD |
| Selling, general, and administrative | 95.04M USD | 71.58M USD | 64.03M USD | 52.11M USD | 44.3M USD |
| Operating expenses | 95.04M USD | 71.58M USD | 64.03M USD | 52.11M USD | 44.3M USD |
| Interest income | — | 825K USD | 808K USD | — | — |
| Interest expense | 5.27M USD | 798K USD | 1.84M USD | 2.42M USD | 810K USD |
| Depreciation and amortization | 26.17M USD | 18.57M USD | 13.54M USD | 10.96M USD | 9.57M USD |
| Operating income | 13.26M USD | 17.87M USD | 19.78M USD | 16.25M USD | 14.14M USD |
| Net income | 5.38M USD | 14.52M USD | 13.65M USD | 10.69M USD | 11.38M USD |
Company facts updated Oct 8, 2026.
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI25.8M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 ETFIWM21.97M0.03%78.56B USD0.19%$277.57-0.05%
Thrivent Small-Mid Cap Equity ETFTSME10.82M1.21%895.7M USD0.65%$46.29-0.96%
Vanguard Extended Market ETFVXF9.43M0.01%95.4B USD0.05%$233.13-0.15%
Dimensional - US Targeted Value ETFDFAT6.68M0.02%30B USD0.33%$67.56+0.72%
Dimensional - US Small Cap ETFDFAS6.35M0.02%33.66B USD0.31%$78.10+0.23%
Vanguard Russell 2000 ETFVTWO4.66M0.03%18B USD0.06%$112.1-0.10%
Schwab U.S. Small-Cap ETFSCHA4.44M0.02%21.7B USD0.03%$32.66+0.15%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMThrivent Small-Mid Cap Equity ETFTSMEVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATDimensional - US Small Cap ETFDFASVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
